Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.371,56
0,94%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Molecular Insight Pharmaceuticals (MM) (MIPI) Molecular Insight Pharmaceuticals (MM) (MIPI) Notizie

MIPI

Molecular Insight Pharmaceuticals (MM) (MIPI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MIPI
DataOraFonteTitoloSimboloCompagnia
21/12/201001:42MarketwiredMolecular Insight Announces NASDAQ Decision to Delist Common Stock and Transfer to OTCQB(TM) MarketplaceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/12/201017:18Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/12/201022:39Edgar (US Regulatory)Current report filing (8-K)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
10/12/201004:46MarketwiredMolecular Insight Announces $45-Million Financing Commitment, Chapter 11 Filing, Corporate Restructuring and Management ChangesNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
03/12/201001:38MarketwiredMolecular Insight Receives Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201018:43Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
04/11/201013:21MarketwiredMolecular Insight Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial and Operational ResultsNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201022:30MarketwiredMolecular Insight Pharmaceuticals Data Indicate Trofex(TM) May Enable Visualization and Monitoring of Response to Prostate CanceNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
19/10/201022:01MarketwiredMolecular Insight Announces Resignation of Chief Medical OfficerNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/10/201022:49MarketwiredMolecular Insight Pharmaceuticals Presents Positive Data From Clinical Studies Comparing Trofex(TM) and ProstaScint(R) for DetecNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
08/10/201014:00MarketwiredMolecular Insight Pharmaceuticals Receives NASDAQ Notification LettersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
06/10/201017:47MarketwiredMolecular Insight Receives Eleventh Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201020:58Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/09/201017:16MarketwiredMolecular Insight Receives Tenth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
09/09/201014:00MarketwiredMolecular Insight Receives Ninth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
01/09/201014:01MarketwiredMolecular Insight Receives Eighth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
30/08/201023:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
17/08/201014:04MarketwiredMolecular Insight Receives Seventh Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
02/08/201022:01MarketwiredMolecular Insight Receives Sixth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
16/07/201014:01MarketwiredMolecular Insight Receives Fifth Extension of Waiver Agreement with Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
14/07/201014:01MarketwiredMolecular Insight Pharmaceuticals' Zemiva Phase 2 Data Published in Journal of the American College of CardiologyNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
02/07/201014:09MarketwiredMolecular Insight Receives Fourth Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
01/07/201012:03Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
30/06/201020:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/A)NASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
25/06/201014:01MarketwiredMolecular Insight Pharmaceuticals Receives NASDAQ Notification LetterNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
23/06/201022:01MarketwiredMolecular Insight Pharmaceuticals Presents Positive Data From Azedra(TM) Phase 2a Clinical Trial in Neuroblastoma TumorsNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
22/06/201014:01MarketwiredMolecular Insight Receives Third Extension of Waiver Agreement With Bond holdersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
16/06/201012:50GlobeNewswire Inc.Stock Alert for Molecular Insight Pharmaceuticals Inc. Issued by MicroStockProfitNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
08/06/201022:30MarketwiredMolecular Insight Pharmaceuticals Presents Oncology Data at Society of Nuclear Medicine 2010 Annual MeetingNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
18/05/201014:00MarketwiredMolecular Insight Receives Second Extension of Waiver Agreement With Bond HoldersNASDAQ:MIPIMolecular Insight Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MIPI

La tua Cronologia

FX
CADNOK
CAD vs NOK
GATE
ARNXUSDT
Aeron
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network